Yum China Holdings, Inc. (NYSE:YUMC) shares are trading higher on Thursday after the fourth-quarter FY24 earnings result. The ...

Shares of data analytics firm Equifax Inc (EFX) fell nearly 7% on Thursday, heading toward their worst single-day session ...

Murphy USA Inc. (NYSE:MUSA), a $10.02 billion market cap fuel retailer, reported its earnings for the fourth quarter of 2024, ...

ConocoPhillips (NYSE:COP) shares are trading higher after the company released fourth-quarter results. Here’s a breakdown of ...

Management projected life premium revenue growth of 4.5–5% for 2025, compared to 4% in 2024, and health premium revenue growth of 7.5–8.5%, up from 6.5% in 2024. Life underwriting margin is ...

Jay Sugarman, Chairman and CEO, emphasized two key initiatives for 2025: expanding Safehold’s penetration in the multifamily affordable housing market and implementing a $50M share buyback ...

Eli Lilly reported mixed fourth-quarter results on Thursday, surpassing earnings expectations but falling short of sales projections, even as demand for its flagship weight loss drug Zepbound and ...

MCD's fourth-quarter 2024 top line is likely to have been aided by strong digital adoption, innovative menu additions and ...

Although the revenue and EPS for Bristol Myers (BMY) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall ...

Adjusted EBITDA of $996 M for the fourth quarter, $3,684 Mfor the full year;R&D Solutions quarterly bookings of over $2.5 billion, representing a book-to-bill ratio of 1.20x ;R&D Solutions contracted ...

Yum Brands Q4 Worldwide Systems Sales Ex-Forex Up 8%; Opened 1,804 Gross Units in Q4… David Gibbs, CEO, said “2024 was marked with exceptional core operating profit growth given the complex consumer ...

Eli Lilly's Q4 revenue surged 45% to $13.53 billion, fueled by Mounjaro and Zepbound. 2025 guidance forecasts up to $61 billion in sales, driven by new drug launches.